696 related articles for article (PubMed ID: 22353773)
1. Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers.
van Schooneveld E; Wouters MC; Van der Auwera I; Peeters DJ; Wildiers H; Van Dam PA; Vergote I; Vermeulen PB; Dirix LY; Van Laere SJ
Breast Cancer Res; 2012 Feb; 14(1):R34. PubMed ID: 22353773
[TBL] [Abstract][Full Text] [Related]
2. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
3. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
5. Identification of circulating microRNA signatures for breast cancer detection.
Chan M; Liaw CS; Ji SM; Tan HH; Wong CY; Thike AA; Tan PH; Ho GH; Lee AS
Clin Cancer Res; 2013 Aug; 19(16):4477-87. PubMed ID: 23797906
[TBL] [Abstract][Full Text] [Related]
6. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
7. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort.
Godfrey AC; Xu Z; Weinberg CR; Getts RC; Wade PA; DeRoo LA; Sandler DP; Taylor JA
Breast Cancer Res; 2013 May; 15(3):R42. PubMed ID: 23705859
[TBL] [Abstract][Full Text] [Related]
9. Direct Comparison of Metastasis-Related miRNAs Expression Levels in Circulating Tumor Cells, Corresponding Plasma, and Primary Tumors of Breast Cancer Patients.
Markou A; Zavridou M; Sourvinou I; Yousef G; Kounelis S; Malamos N; Georgoulias V; Lianidou E
Clin Chem; 2016 Jul; 62(7):1002-11. PubMed ID: 27197674
[TBL] [Abstract][Full Text] [Related]
10. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
Schrauder MG; Strick R; Schulz-Wendtland R; Strissel PL; Kahmann L; Loehberg CR; Lux MP; Jud SM; Hartmann A; Hein A; Bayer CM; Bani MR; Richter S; Adamietz BR; Wenkel E; Rauh C; Beckmann MW; Fasching PA
PLoS One; 2012; 7(1):e29770. PubMed ID: 22242178
[TBL] [Abstract][Full Text] [Related]
11. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
12. The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.
Gravgaard KH; Lyng MB; Laenkholm AV; Søkilde R; Nielsen BS; Litman T; Ditzel HJ
Breast Cancer Res Treat; 2012 Jul; 134(1):207-17. PubMed ID: 22294488
[TBL] [Abstract][Full Text] [Related]
13. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
McDermott AM; Miller N; Wall D; Martyn LM; Ball G; Sweeney KJ; Kerin MJ
PLoS One; 2014; 9(1):e87032. PubMed ID: 24498016
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers.
Zearo S; Kim E; Zhu Y; Zhao JT; Sidhu SB; Robinson BG; Soon PSh
BMC Cancer; 2014 Mar; 14():200. PubMed ID: 24641801
[TBL] [Abstract][Full Text] [Related]
16. Impact of tumour epithelial subtype on circulating microRNAs in breast cancer patients.
Waters PS; Dwyer RM; Brougham C; Glynn CL; Wall D; Hyland P; Duignan M; McLoughlin M; Newell J; Kerin MJ
PLoS One; 2014; 9(3):e90605. PubMed ID: 24626163
[TBL] [Abstract][Full Text] [Related]
17. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies.
McDermott AM; Kerin MJ; Miller N
PLoS One; 2013; 8(12):e83718. PubMed ID: 24391813
[TBL] [Abstract][Full Text] [Related]
19. Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.
Al-Khanbashi M; Caramuta S; Alajmi AM; Al-Haddabi I; Al-Riyami M; Lui WO; Al-Moundhri MS
PLoS One; 2016; 11(4):e0152032. PubMed ID: 27064979
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
Mishra S; Srivastava AK; Suman S; Kumar V; Shukla Y
Cancer Lett; 2015 Dec; 369(1):67-75. PubMed ID: 26276721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
